期刊文献+

溶血磷脂酸促卵巢癌细胞增殖机制的研究 被引量:4

Mechanisms involved in lysophosphatidic acid inducing proliferation of ovarian carcinoma cells
原文传递
导出
摘要 目的探讨溶血磷脂酸(LPA)促进卵巢癌细胞增殖的机制。方法体外培养人卵巢上皮癌细胞株SKOV3,选用促分裂素原活化蛋白激酶(MAPK)信号传导通路特异性阻断剂PD98059,应用四甲基偶氮唑蓝(MTT)比色法测定LPA和PD98059对SKOV3细胞增殖活性的影响;应用实时荧光定量PCR(RT-PCR)测定LPA单独或合用PD98059对SKOV3细胞表达环氧化酶-2(COX-2)的影响;应用流式细胞仪(FCM)测定细胞的凋亡及细胞周期的变化。结果 LPA(浓度>10μmol/L)以剂量依赖方式促进SKOV3细胞增殖,PD98059抑制LPA促增殖作用(P<0.05)。RT-PCR结果显示,LPA能促进COX-2的表达(P<0.05),而合用PD98059后COX-2的表达降低(P<0.05)。FCM结果显示,LPA能促进细胞增殖,抑制细胞凋亡,增加S期比率,而合用PD98059后LPA促增殖作用消失,且G0/G1期比率升高,S期比率降低。结论 LPA通过MAPK信号传导通路促进卵巢癌细胞增殖,且与COX-2表达有关。 Objective To investigate the mechanism of lysophosphatidic acid(LPA) inducing proliferation of ovarian carcinoma cells.Methods The human ovarian cancer cell line SKOV3 was cultured in vitro,and PD98059 which could inhibit the mitogen-activated protein kinase(MAPK) signaling pathway was used.Proliferative activity of SKOV3 cells stimulated by LPA with or without PD98059 was assessed by Methyl thiazolyl tetrazolium(MTT).Expression of COX-2 in SKOV3 cells was assessed by RT-PCR.Apoptosis and cell cycle of SKOV3 cells were detected by flow cytometry(FCM).Results LPA(when density 10 μmol/L) could promote proliferation of SKOV3 cells in a dose-dependent manner,while PD98059 could inhibit the effect(P〈0.05).RT-PCR showed that LPA could increase expression of COX-2 in SKOV3 cells(P〈0.05),while PD98059 could decrease the effect(P〈0.05).FCM showed that LPA could promote proliferation,inhibit apoptosis,and increase the proportion of cells in the S phase.However,combined with PD98059 in culture,cell proliferation and proportion of cells in the S phase were significantly decreased,while the proportion of cells in the G0/G1 phase was increased.Conclusion LPA may promote proliferation of ovarian carcinoma cells via the MAPK signaling pathway,and the mechanism is related to expression of COX-2.
作者 丁萍萍 李强
出处 《山东大学学报(医学版)》 CAS 北大核心 2011年第7期35-38,43,共5页 Journal of Shandong University:Health Sciences
基金 山东省优秀中青年科学家科研奖励基金资助课题(03BS034)
关键词 溶血磷脂酸 卵巢肿瘤 MAPK信号传导通路 增殖 Lysophosphatidic acid Ovarian neoplasms Mitogen-activated protein kinase signaling pathway Proliferation
  • 相关文献

参考文献12

  • 1Zeng P, Wagoner H A, Pescovitz O H, et al. RNA inter- ference (RNAi) for extracellular signal-regulated kinase I (ERK1) alone is sufficient to suppress cell viability in o- varian cancer cells[J].Cancer Biol Ther, 2005, 4 ( 9 ) : 961-967.
  • 2李宗斌,陈玉霞,赵洁莹,卢建.药物治疗浓度的雌激素对卵巢癌3AO细胞生长的影响(英文)[J].Acta Genetica Sinica,2006,33(9):782-792. 被引量:3
  • 3Ren J, Xiao Y J, Singh L S, et al. Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells[J].Cancer Res, 2006, 66 ( 6 ) : 3006-3014.
  • 4Base T, Batbaros M, Baykara E, et al. Comparison of total plasma lysophosphatidic acid and serum CA-125 as a tumor marker in the diagnosis and follow up of patients with epithelial ovarian cancer [ J]. Gynecol Oncol, 2010, 21 (4) :248-254.
  • 5李强,王伟,王强修,连岩,孟燕.LPA、CA125与经阴道彩色多普勒超声联合诊断卵巢上皮癌的临床价值[J].现代妇产科进展,2010,19(11):832-834. 被引量:6
  • 6Hong Sun,Juan Ren,Qing Zhu,Fan-Zhong Kong,Lei Wu,Bo-Rong Pan.Effects of lysophosphatidic acid on human colon cancer cells and its mechanisms of action[J].World Journal of Gastroenterology,2009,15(36):4547-4555. 被引量:7
  • 7孙红,朱青,任娟,吴磊,孔繁忠,李光,胡海峰.溶血磷脂酸对宫颈癌细胞增殖、黏附、迁移和凋亡的影响[J].细胞与分子免疫学杂志,2009,25(8):702-705. 被引量:13
  • 8Lee C W, Kim N H, Choi H K, et al. Lysophosphatidic acid-induced c-fos up-regulation involves cyclic AMP re- sponse element-binding protein activated by mitogen- and stress-activated protein kinase-1 [ J ]. Cell Biochem, 2008, 104:785-794.
  • 9Hu Y L, Albanese C, Pestell R G, et al. Dual mecha- nisms for lysophosphatidic acid stimulation of human o-varian carcinoma cells [ J ]. Natl Cancer Inst, 2003, 95 (10) :733-740.
  • 10Symowicz J, Adley B P, Woo M M, et al. Cyclooxyge- nase-2 functions as a downstream mediator of lysophos- phatidic acid to promote aggressive behavior in carcino- ma cells[J].Cancer Res, 2005, 65(6) :2234-2242.

二级参考文献41

  • 1滕振平,邢飞跃,王通,李莉平.细胞外信号调节激酶1/2的阻断剂PD98059对小鼠淋巴细胞增殖的影响[J].细胞与分子免疫学杂志,2007,23(2):102-105. 被引量:4
  • 2Lu JB,Sun XB,Dai DX,Zhu SK,Chang QL,Liu SZ,Duan WJ.Epidemiology of gastroenterologic cancer in Henan Province,China.World J Gastroenterol 2003; 9:2400-2403.
  • 3Yiu HY,Whittemore AS,Shibata A.Increasing colorectal cancer incidence rates in Japan.Int J Cancer 2004; 109:777-781.
  • 4Erickson JR,Hasegawa Y,Fang X,Eder A,Mao M,Furui T,Aoki J,Morris A,Mills GB.Lysophosphatidic acid and ovarian cancer:a paradigm for tumorogenesis and patient management.Prostaglandins 2001; 64:63-81.
  • 5Ishii I,Fukushima N,Ye X,Chun J.Lysophospholipid receptors:signaling and biology.Annu Rev Biochem 2004; 73:321-354.
  • 6Panetti TS.Differential effects of sphingosine 1-phosphate and lysophosphatidic acid on endothelial cells.Biochim Biophys Acta 2002; 1582:190-196.
  • 7Zhao Z,Xiao Y,Elson P,Tan H,Plummer SJ,Berk M,Aung PP,Lavery IC,Achkar JP,Li L,Casey G,Xu Y.Plasma lysophosphatidylcholine levels:potential biomarkers for colorectal cancer.J Clin Oncol 2007; 25:2696-2701.
  • 8Shida D,Watanabe T,Aoki J,Hama K,Kitayama J,Sonoda H,Kishi Y,Yamaguchi H,Sasaki S,Sako A,Konishi T,Arai H,Nagawa H.Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer.Lab Invest 2004;84:1352-1362.
  • 9Kishi Y,Okudaira S,Tanaka M,Hama K,Shida D,Kitayama J,Yamori T,Aoki J,Fujimaki T,Arai H.Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid.J Biol Chem 2006; 281:17492-17500.
  • 10Lee CW,Kim NH,Choi HK,Sun Y,Nam JS,Rhee HJ,Chun J,Huh SO.Lysophosphatidic acid-induced c-fos upregulation involves cyclic AMP response element-binding protein activated by mitogen-and stress-activated protein kinase-1.J Cell Biochem 2008; 104:785-794.

共引文献24

同被引文献34

  • 1罗威,曹亚.靶向ERK信号转导通路抗肿瘤的研究进展[J].国际病理科学与临床杂志,2006,26(3):200-203. 被引量:7
  • 2Brozovic A,Osmak M.Activation of mitogen-activated pro-tein kinases by cisplatin and their role in cisplatin resist-ance[J].Cancer Lett,2007,251(1):11-16.
  • 3Hirama M,Isonishi S,Yasuda M,et al.Characterization ofmitochondria in cisplatin-resistant human ovarian carcino-ma cells[J].Oncol Rep,2006,16(5):997-1002.
  • 4Ren J,Xiao Y J,Singh L S,et al.Lysophosphatidic acid isconstitutively produced by human peritoneal mesothelialcells and enhances adhesion,migration,and invasion of o-varian cancer cells[J].Cancer Res,2006,66(6):3006-3014.
  • 5Fuiita T,Washio K,Takabatake D,et al.Proteasome inhib-itors can alter the signaling pathways and attenuate the Pglycoprotein-mediated muhidrug resistance[J].Int JCancer,2005,117(4):670-682.
  • 6Sakamoto S, Yokoyama M, Zhang X, et al. Increased expres- sion of CYR61, an extracellular matrix signaling protein, in human benign prostatic hyperplasia and its regulation by ly- sophosphatidic acid [ J ]. Endocrinology, 2004, 145 ( 6 ) : 2929-2940.
  • 7Mills GB, May C, McGill M, et al. A putative new growth factor inascitic fluid from ovanrian cancer patients:identifi- cation, charaterization, andmechanism of action [ J ]. Can- cerRes, 1988,48 : 1066-1071.
  • 8Shen Z, Wu M, Elson P, et al. Fatty acid composition of lyso- phosphatidic acid and lysophosphatidylinosital in plasma from patients with ovarian cancer and other gynecological diseases[ J]. Gynecol, Oncol 2001,83 ( 1 ) :25-30.
  • 9Ren J, Xiao Y J, Singh L S, et al. Lysophosphatidic acid is constitutively producedby human peritoneal mesothelial ceils and enhances adhesion, migration, and invasion of ovar- ian cancer cells[J]. Cancer Res,2006,66 (6) :3006-3014.
  • 10Base T, Batbaros M, Baykara E, et al. Comparison of total plasma lysophosphatidic acid and serum CA-125 as a tumor marker in the diagnosis and follow up of patients with epithe- lial ovarian cancer [ J ]. Gynecol Oncol, 2010,21 ( 4 ) : 248- 254.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部